March 18, 2025

FDA Approves Expanded Label for ILUVIEN

The fluocinolone acetonide intravitreal implant is now indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, as well as DME.

Conexiant

March 17, 2025

How Spaceflight Alters Human Physiology

From bone loss to vision impairment, spaceflight triggers changes in human physiology.

Reuters

March 14, 2025

Study Demonstrates Outcomes of CNV Removal for hESC-RPE

“Safe CNV removal is a prerequisite for successful hESC-RPE transplantation in patients with wet AMD,” researchers found.

Conexiant

March 11, 2025

Pregnancy Triggers Multiple Eye Changes, New Review Finds

"New glasses or refractive surgeries should be avoided until after the end of pregnancy, once visual function has stabilized or returned to the prepregnancy state," researchers recommended.

Conexiant

March 06, 2025

Private Equity Acquisitions Affect Industry Payments for Ophthalmologists

“It is unknown whether PE firms affect the financial incentives offered to physicians by other industry actors, which may change clinical decision-making," researchers note.

Conexiant

March 04, 2025

Uncertainties about Geographic Atrophy Complement Inhibition Therapy

Functional benefits and safety remain in question, despite anatomical benefits shown in trials.

Conexiant

March 01, 2025

Refining a Deep Learning Model’s Ability to Identify GA Area

The GEODE study evaluated the use of 3D volumetric OCT data to accurately segment the area.

Retinal Physician

March 01, 2025

Managing Geographic Atrophy and Intravitreal Injections

Explore key challenges and protocols in treating geographic atrophy in ophthalmology, as described by Dr. Harit Bhatt.

Retinal Physician

March 01, 2025

Complement Inhibition for Geographic Atrophy

Inhibition of the complement system offers a promising approach to slow GA progression, but challenges remain.

Retinal Physician